These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Experimentally induced liver metastases from colorectal cancer can be prevented by mononuclear phagocyte-mediated monoclonal antibody therapy. van der Bij GJ; Bögels M; Otten MA; Oosterling SJ; Kuppen PJ; Meijer S; Beelen RH; van Egmond M J Hepatol; 2010 Oct; 53(4):677-85. PubMed ID: 20619916 [TBL] [Abstract][Full Text] [Related]
30. Does hypervascularity of liver metastases as detected on MRI predict disease progression in breast cancer patients? Braga L; Semelka RC; Pietrobon R; Martin D; de Barros N; Guller U AJR Am J Roentgenol; 2004 May; 182(5):1207-13. PubMed ID: 15100120 [TBL] [Abstract][Full Text] [Related]
31. A radiologist's guide to treatment response criteria in oncologic imaging: functional, molecular, and disease-specific imaging biomarkers. Rezai P; Pisaneschi MJ; Feng C; Yaghmai V AJR Am J Roentgenol; 2013 Aug; 201(2):246-56. PubMed ID: 23883206 [TBL] [Abstract][Full Text] [Related]
32. A radiologist's guide to treatment response criteria in oncologic imaging: anatomic imaging biomarkers. Rezai P; Pisaneschi MJ; Feng C; Yaghmai V AJR Am J Roentgenol; 2013 Aug; 201(2):237-45. PubMed ID: 23883205 [TBL] [Abstract][Full Text] [Related]
33. [Molecular targeted therapy strategies for primary liver cancer]. He XX; Ren HP; Li Y; Lin JS Zhonghua Gan Zang Bing Za Zhi; 2011 Aug; 19(8):561-2. PubMed ID: 22152308 [No Abstract] [Full Text] [Related]
34. Innovative Therapeutic Strategies in the Molecular Targeting Era. Nishimura JI Curr Med Chem; 2020; 27(25):4155-4156. PubMed ID: 32571196 [No Abstract] [Full Text] [Related]
36. Comparison of CT Volumetry and RECIST to Predict the Treatment Response and Overall Survival in Gastric Cancer Liver Metastases. Yu SH; Choi SJ; Noh H; Lee IS; Park SH; Kim SJ Taehan Yongsang Uihakhoe Chi; 2021 Jul; 82(4):876-888. PubMed ID: 36238076 [TBL] [Abstract][Full Text] [Related]
37. Characterization of Anti-Angiogenic Chemo-Sensitization via Longitudinal Ultrasound Localization Microscopy in Colorectal Carcinoma Tumor Xenografts. Lowerison M; Zhang W; Chen X; Fan T; Song P IEEE Trans Biomed Eng; 2022 Apr; 69(4):1449-1460. PubMed ID: 34633926 [TBL] [Abstract][Full Text] [Related]
38. Impact of Variability in Portal Venous Phase Acquisition Timing in Tumor Density Measurement and Treatment Response Assessment: Metastatic Colorectal Cancer as a Paradigm. Dercle L; Lu L; Lichtenstein P; Yang H; Wang D; Zhu J; Wu F; Piessevaux H; Schwartz LH; Zhao B JCO Clin Cancer Inform; 2017 Nov; 1():1-8. PubMed ID: 30657405 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of Alterations in Tumor Tissue of Gastrointestinal Stromal Tumor (GIST) in Computed Tomography Following Treatment with Imatinib. Werewka-Maczuga A; Stępień M; Urbanik A Pol J Radiol; 2017; 82():817-826. PubMed ID: 29657650 [TBL] [Abstract][Full Text] [Related]
40. Molecular Targeted Therapy in Modern Oncology: Imaging Assessment of Treatment Response and Toxicities. Krajewski KM; Braschi-Amirfarzan M; DiPiro PJ; Jagannathan JP; Shinagare AB Korean J Radiol; 2017; 18(1):28-41. PubMed ID: 28096716 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]